Treatment Outcome of Resection of Disseminated Peritoneal Metastases from Colorectal Cancer.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 03 03 2020
revised: 30 03 2020
accepted: 01 04 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 22 6 2021
Statut: ppublish

Résumé

To show the treatment outcomes of disseminated nodule resection for peritoneal metastasis of colorectal cancer and describe the details of cured cases. From January 2001 to December 2016, patients who underwent disseminated nodule resection of colorectal adenocarcinoma with no macroscopic residual tumor in our institution were retrospectively analyzed for clinicopathological factors associated with prognosis. Forty-one cases were included in this study. The 3-year relapse-free survival was 12.5%, and the 5-year overall survival was 38.4%. In a multivariate analysis, lack of post-operative adjuvant chemotherapy and pre-operative carbohydrate antigen 19-9 over 100 IU/l were extracted as independent factors associated with short relapse-free survival, respectively. Among 41 cases, 32 were followed-up 5 years after surgery and five (15.6%) survived without relapse and were regarded as 'cured'. More than a few cases of colorectal peritoneal metastasis, which is thought to be difficult to cure, were cured by resection of disseminated nodules without resorting to highly invasive treatment.

Identifiants

pubmed: 32606163
pii: 34/4/1915
doi: 10.21873/invivo.11988
pmc: PMC7439882
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1915-1920

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

BMC Cancer. 2010 Dec 22;10:689
pubmed: 21176206
Clin Colorectal Cancer. 2014 Jun;13(2):87-93
pubmed: 24373733
J Am Coll Surg. 2014 Apr;218(4):573-85
pubmed: 24491244
Ann Surg Oncol. 2007 Feb;14(2):786-94
pubmed: 17103254
Eur J Surg Oncol. 2005 Dec;31(10):1145-51
pubmed: 16084051
Lancet Oncol. 2012 Aug;13(8):e362-9
pubmed: 22846841
Ann Surg Oncol. 2017 May;24(5):1269-1280
pubmed: 27995451
Gan To Kagaku Ryoho. 2013 Nov;40(12):1626-8
pubmed: 24393870
Eur J Surg Oncol. 2018 Dec;44(12):1942-1948
pubmed: 30075978
Ann Surg. 2013 Jun;257(6):1065-71
pubmed: 23299520
Am J Clin Oncol. 2013 Apr;36(2):157-61
pubmed: 22314003
Ann Surg Oncol. 2017 Apr;24(4):884-889
pubmed: 27896506
Surg Today. 2014 Sep;44(9):1643-50
pubmed: 24077999
J Gastroenterol. 2014 Apr;49(4):646-54
pubmed: 23793379
Anticancer Res. 2009 Oct;29(10):4303-8
pubmed: 19846991
Ann Surg Oncol. 2017 Dec;24(13):3825-3830
pubmed: 29019118
J Clin Oncol. 2012 Jan 20;30(3):263-7
pubmed: 22162570

Auteurs

Gaku Ohira (G)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan Ohira@faculty.chiba-u.jp.

Hideaki Miyauchi (H)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Koichi Hayano (K)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Michihiro Maruyama (M)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Shunsuke Imanishi (S)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Toru Tochigi (T)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Tetsuro Maruyama (T)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Toshiharu Hanaoka (T)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Koichiro Okada (K)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Hisahiro Matsubara (H)

Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH